Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Bone Marrow Transplantation|May 1, 1996
Comparative analysis of two consecutive phase II studies with IFN-alpha and IFN-alpha + ara-C in untreated chronic-phase CML patients. Austrian CML Study GroupJ Thaler, W HilbePadiatrie Und Padologie|January 1, 1981
[Hyperammonemia in the newborn through ornithine transcarbamylase deficiency (author's transl)]E Plöchl, W Hilbe, C BachmannActa Haematologica|October 26, 1999
Cladribine treatment of a patient with hairy cell leukemia and concomitant multiple sclerosisW Hilbe, T Berger, G Konwalinka, et al.European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 29, 2004
Biomarkers in non-small cell lung cancer preventionW Hilbe, S Dirnhofer, R Greil, et al.Acta Endocrinologica. Supplementum|January 1, 1986
Prostaglandin excretion in pseudohypoaldosteronism type IE A Werder, W Hilbe, M B VallottonActa Haematologica|January 1, 1997
T cells and natural killer cells after treatment of hairy cell leukaemia with 2-chlorodeoxyadenosineM Schirmer, W Hilbe, F Geisen, et al.Leukemia Research|September 1, 1994
Treatment of relapsed and refractory acute myelogenous leukaemia with aclacinomycin A (ACA) and etoposide (VP-16)W Hilbe, J Thaler, W Eisterer, et al.Wiener Klinische Wochenschrift|November 9, 1979
[Preliminary findings with oral whooping cough vaccination in young infants (author's transl)]H Maurer, K H Höfler, W Hilbe, et al.British Journal of Haematology|November 1, 1995
Decreased potency of MDR-modulators under serum conditions determined by a functional assayC Ludescher, W Eisterer, W Hilbe, et al.Biochemical Pharmacology|October 17, 1998
PKC-independent modulation of multidrug resistance in cells with mutant (V185) but not wild-type (G185) P-glycoprotein by bryostatin 1M Spitaler, I Utz, W Hilbe, et al.Pageof 5